journal
Journals International Journal of Tuber...

International Journal of Tuberculosis and Lung Disease

https://read.qxmd.com/read/38303038/nirmatrelvir-ritonavir-and-pharmacovigilance-data
#21
JOURNAL ARTICLE
S Lassan, M Gocova, I Solovic, T Tesar, Z Motesicka, M Lassanova
No abstract text is available yet for this article.
February 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38303037/compliance-with-new-drug-use-and-the-effect-of-discrepant-drug-susceptibility-testing-on-mdr-rr-tb-treatment
#22
JOURNAL ARTICLE
J E Shin, D Jeon, J Mok, J-J Yim, Y-S Kwon, K-W Jo, T S Shim
BACKGROUND: Following the WHO???s announcement in 2018, the use of new drugs was recommended for all patients with multidrug-resistant TB (MDR-TB) in Korea. This study aimed to evaluate adherence to new anti-TB drug regimens and implementation of molecular drug susceptibility testing (mDST) in Korea. METHODS: Nationwide, 560 patients were reported as having MDR-TB in 2021. The implementation of mDST and new anti-TB drug use were analysed. The discrepancy between mDST and phenotypic DST (pDST) results and their implications on the use of new anti-TB drugs were also analysed...
February 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38303036/increasing-incidence-of-tb-in-a-low-burden-tb-country-due-to-migration-from-ukraine
#23
JOURNAL ARTICLE
K Doležalová, V Kika, J Wallenfels
No abstract text is available yet for this article.
February 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38303035/community-level-variation-in-tb-testing-history-in-blantyre-malawi
#24
JOURNAL ARTICLE
E S Nightingale, H R A Feasey, M Khundi, R N Soko, R M Burke, M Nliwasa, H Twabi, J A Mpunga, K Fielding, P MacPherson, E L Corbett
SETTING: Equitable access to TB testing is vital for achieving global diagnosis and treatment targets, but access to diagnostic services is often worse in poorer communities. The SCALE (Sustainable Community-wide Active case-finding for Lung hEalth) survey estimated TB prevalence in Blantyre City, Malawi, and recorded previous engagement with TB services. OBJECTIVE: To explore local variation in the prevalence of ever-testing for TB in Blantyre and investigate potential socio-economic drivers. DESIGN: We fit a mixed-effects model to self-reported prior TB testing from survey participants across 72 neighbourhood clusters, adjusted for sex, age and HIV status and with cluster-level random intercepts...
February 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178302/ethambutol-induced-optic-neuropathy-should-we-mandate-ophthalmic-examination-in-tb-treatment
#25
JOURNAL ARTICLE
S R Kumar, S S Hissar, P M Ramesh, M Shanmugam, V Kalaiselvan, J Prakash, C Padmapriyadarsini
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178301/the-urgent-need-to-improve-on-low-implementation-rates-for-tb-preventive-treatment-for-people-living-with-hiv
#26
JOURNAL ARTICLE
M Cossa, D Nguenha, A Houana, J Ehrlich, S Acácio, A L Garcia-Basteiro
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178300/long-term-follow-up-of-persons-diagnosed-with-multidrug-resistant-tb-in-chennai-india-2013-2020
#27
JOURNAL ARTICLE
D Surie, M K Sathyanarayanan, J Lavanya, J P Smith, S K Shanmugam, S Tamilzhalagan, A Selvaraj, G Ramesh, S Tripathy, S D Khaparde, C S Ho, P J Hall-Eidson, U D K Ranganathan, S Selvaraju, P K Moonan
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178299/ten-common-myths-about-drug-susceptible-tb
#28
JOURNAL ARTICLE
N Riccardi, R M Antonello, G Besozzi, M Tadolini, L Codecasa
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178298/efficacy-and-safety-of-bicyclol-for-treating-patients-with-antituberculosis-drug-induced-liver-injury
#29
JOURNAL ARTICLE
Y Du, J Gu, Y Yang, Y Chen, Y Wang, Z Mei, Y Li, L Li, D Xue, X Wang, D Li, P Hu, W Nie, N Chu
BACKGROUND: Bicyclol was used for treating idiosyncratic acute drug-induced liver injury (DILI) in a phase II trial. This study was aimed at evaluating the efficacy and safety of bicyclol 25 and 50 mg thrice a day (TID) for treating acute DILI caused by anti-TB drugs in the light of the trial results. METHODS: We analysed clinical data of patients with TB drug-induced DILI in the trial database. The primary endpoint was reduction in serum alanine aminotransferase (ALT) levels after 4 weeks of treatment compared to baseline...
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178297/cost-effectiveness-of-expanded-latent-tb-infection-testing-and-treatment-lynn-city-massachusetts-usa
#30
JOURNAL ARTICLE
G R Beeler Asay, R Woodruff, D M Sanderson, C F Fisher, S M Marks, V D Green, A M Tibbs, A N Hill, H H Haptu, D McManus, R K Paradise, C Auguste-Nelson, J J Cochran
BACKGROUND: Between October 2016 and March 2019, Lynn Community Health Center in Massachusetts implemented a targeted latent TB infection testing and treatment (TTT) program, increasing testing from a baseline of 1,200 patients tested to an average of 3,531 patients tested, or 9% of the population per year. METHODS: We compared pre-implementation TTT, represented by the first two quarters of implementation data, to TTT, represented by 12 quarters of data. Time, diagnostic, and laboratory resources were estimated using micro-costing...
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178296/if-you-want-to-go-far-go-together-standardisation-and-data-sharing-in-tb-drug-development
#31
JOURNAL ARTICLE
J A Schildkraut, D Sloan, M J Boeree
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178295/estimating-tb-survival-mind-the-immortal-time-gap
#32
JOURNAL ARTICLE
R M G J Houben, T McCaffrey, E W Tiemersma, P Y Khan
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178294/prevalence-temporal-trends-and-risk-factors-of-drug-resistant-tb-in-zibo-china-2018-2021
#33
JOURNAL ARTICLE
Shaozhan Yuan, Yong Cui, Yongming Shang, Feiya Su, Yan Liu, Haiyan Shi
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178293/exploring-hiv-disease-indicators-at-mdr-tb-treatment-initiation-in-south-africa
#34
RANDOMIZED CONTROLLED TRIAL
K Geiger, A Patil, A Bergman, C Budhathoki, O Heidari, K Lowensen, N Mthimkhulu, K C McNabb, N N Mmed, J Ngozo, N Reynolds, J E Farley
BACKGROUND: Understanding relationships between HIV and multidrug-resistant TB (MDR-TB) is crucial for ensuring successful MDR-TB outcomes. METHODS: We used a cross-sectional analysis to evaluate sociodemographic and clinical characteristics as correlates of antiretroviral therapy (ART) use, having an HIV viral load (VL) result, and HIV viral suppression in a cross-sectional sample of people with HIV (PWH) and MDR-TB enrolled in a cluster-randomized trial of nurse case management to improve MDR-TB outcomes...
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178292/geographical-differences-in-chronic-obstructive-pulmonary-disease-mortality-trends-by-sex-spain-1980-2021
#35
JOURNAL ARTICLE
L Cayuela, J L López-Campos, A M Gaeta, R Reinoso-Arija, A Cayuela
BACKGROUND: To analyse changes in trends in mortality due to chronic obstructive pulmonary disease (COPD) in Spain by Autonomous Community (AC) and sex during the period 1980-2021. METHODS: Data on population and COPD death records (International Classification of Diseases, 10th edition, codes J40â-"J44 and J47) were retrieved from the National Institute of Statistics for the study period. Age-standardised mortality rates by AC and sex were assessed using joinpoint regression models. RESULTS: There were 562,668 deaths due to COPD (423,855 in men and 138,813 in women), with an average annual increase of 1...
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178291/armand-van-deun-pioneering-public-health-physician-1953-2023
#36
JOURNAL ARTICLE
H L Rieder, E Declercq, L Rigouts, A Piubello, N E Billo, F Ba, A Trébucq, C-Y Chiang, F Portaels
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178290/anti-tuberculosis-activity-of-morusin-a-promising-flavonoid-from-white-mulberry
#37
JOURNAL ARTICLE
K Yildirim, S Bozkurt, H H Basibuyuk, A Y Coban
BACKGROUND: TB has remained a significant public health concern from historical times to the present day. Each year, growing drug resistance problems necessitate the discovery of new drugs and drug precursors for TB treatment. Morusin is an important flavone found in the bark of white mulberry ( Morus alba L.) with anti-oxidant, antimicrobial, anti-tumour, anti-inflammatory and antiallergic activity. OBJECTIVE: To determine the anti-TB efficacy of morusin on Mycobacterium tuberculosis strains. DESIGN: Anti-TB efficacy of morusin was tested on H37Ra (American Type Culture Collection [ATCC] 25177), H37Rv (ATCC 27294), ATCC 35822 (isoniazid [INH] resistant), ATCC 35838 (rifampicin [RIF] resistant), and ATCC 35820 (streptomycin [SM] resistant) standard strains and its efficacy was determined using nitrate reductase assay (NRA)...
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178289/the-impact-of-sputum-quality-on-xpert-positivity-in-active-case-finding-for-tb
#38
JOURNAL ARTICLE
B Oliveira da Silva, A D Salindri, T O Gonçalves, E A T Cunha, A da Silva Santos, P C P Dos Santos, I B G Lemes, D P B Silva, V da Silva Oliveira, J Croda, R D de Oliveira, J R Andrews
BACKGROUND: Studies evaluating sputum quality and Xpert® MTB/RIF positivity in the context of active case finding are scarce. We aimed to determine whether sputum quality is associated with Xpert positivity and whether the association differed according to demographic and clinical characteristics. METHODS: A cross-sectional analysis using data from a mass screening programme in Brazilian prisons was conducted from 2017 to 2021. We administered a standardised questionnaire, obtained a chest X-ray and collected a spot sputum sample for Xpert testing...
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178288/monitoring-tb-infection-in-contact-cases-the-impact-of-the-covid-19-pandemic
#39
JOURNAL ARTICLE
M Tyufekchieva, T Varleva
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38178287/reply-to-estimating-tb-survival-mind-the-immortal-time-gap
#40
JOURNAL ARTICLE
C A Rodriguez, C R Horsburgh, H E Jenkins, L F White
No abstract text is available yet for this article.
January 1, 2024: International Journal of Tuberculosis and Lung Disease
journal
journal
32735
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.